awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35026994-9E1BD94B-7752-4A3D-A3E9-31499E24710D
Q35026994-9E1BD94B-7752-4A3D-A3E9-31499E24710D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35026994-9E1BD94B-7752-4A3D-A3E9-31499E24710D
Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres
P2860
Q35026994-9E1BD94B-7752-4A3D-A3E9-31499E24710D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35026994-9E1BD94B-7752-4A3D-A3E9-31499E24710D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69e9f342f1085fa715026ec4d4ecbc9571ad441e
P2860
Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial.